Evolus Inc EOLS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EDT
12.39UNCH (UNCH)
Volume
18,138
Close
12.39quote price arrow up+0.70 (+5.99%)
Volume
284,576
52 week range
5.06 - 14.34
Loading...
  • Open11.43
  • Day High12.41
  • Day Low11.07
  • Prev Close11.69
  • 52 Week High14.34
  • 52 Week High Date05/17/22
  • 52 Week Low5.06
  • 52 Week Low Date01/24/22

Key Stats

  • Market Cap694.46M
  • Shares Out56.05M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta2.03
  • YTD % Change90.32

KEY STATS

  • Open11.43
  • Day High12.41
  • Day Low11.07
  • Prev Close11.69
  • 52 Week High14.34
  • 52 Week High Date05/17/22
  • 52 Week Low5.06
  • 52 Week Low Date01/24/22
  • Market Cap694.46M
  • Shares Out56.05M
  • 10 Day Average Volume0.47M
  • Dividend-
  • Dividend Yield-
  • Beta2.03
  • YTD % Change90.32

RATIOS/PROFITABILITY

  • EPS (TTM)-1.30
  • P/E (TTM)-9.54
  • Fwd P/E (NTM)-17.28
  • EBITDA (TTM)-57.018M
  • ROE (TTM)-156.21%
  • Revenue (TTM)121.34M
  • Gross Margin (TTM)57.28%
  • Net Margin (TTM)-58.28%
  • Debt To Equity (MRQ)106.15%

EVENTS

  • Earnings Date08/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Evolus Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Evolus, Inc. is a performance beauty company, which is focused on delivering products in the self-pay aesthetic market. The Company’s first commercial product is Jeuveau, which is an approximately 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical...
Vikram Malik
Chairman of the Board
David Moatazedi
President, Chief Executive Officer, Director
Address
520 Newport Center Dr Ste 1200
Newport Beach, CA
92660-7022
United States

Top Peers

SYMBOLLASTCHG%CHG
SGMO
Sangamo Therapeutics Inc
4.67+0.39+9.11%
NKTR
Nektar Therapeutics
3.93+0.18+4.80%
NSTG
NanoString Technologies Inc
14.10+0.95+7.22%
ADCT
ADC Therapeutics SA
8.85+0.31+3.63%
IMTX
Immatics NV
8.96+0.05+0.56%